• Europe bans anti-obesity drug Reductil

      Comments
      25th Jan 10
      IANS
    London, Jan 26 (IANS) European Medicines Agency (EMEA) has recommended that appetite suppressant drug sibutramine, also known as Reductil, should neither be prescribed by doctors nor dispensed by pharmacists. The regulator has been conducting a safety review and has concluded the increased risks of heart attacks and strokes outweigh the benefits. A trial of 10,000 patients [...]
      News

     
    Read more of . . .

    Europe bans anti-obesity drug Reductil from: IANS. Click here.

     

    See also . . .

    Heart patients using herbal remedies may be at risk. . .
    "Washington, Feb 3 (IANS) Many of today’s popular herbal supplements, including St. John’s wort, ginkgo biloba, garlic and even grapefruit..."
    Family meals, adequate sleep, limited TV may cut childhood obesity risks. . .
    "Washington, February 8 (ANI): Household routines like eating dinner together as a family, getting adequate sleep and limiting television viewing time..."
    Obstructive sleep apnea patients at increased heart disease risk. . .
    "Washington, Jan 25 (ANI): People with obstructive sleep apnea (OSA) are at two-fold risk of dying due to cardiovascular problem, say experts. Over..."
    Dubai opens plant to produce drug for cancer patients. . .
    "Dubai, Jan 28 (IANS) A high-tech facility was inaugurated here in the United Arab Emirates (UAE) to manufacture a drug required in PET (Positron..."

     
    Visited 5 times, 1 so far today

     

    blog comments powered by Disqus

    Via BuzzFeed